193 related articles for article (PubMed ID: 17121855)
1. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Kamei H; Saito T; Ozawa M; Fujita Y; Asada A; Bibb JA; Saido TC; Sorimachi H; Hisanaga S
J Biol Chem; 2007 Jan; 282(3):1687-94. PubMed ID: 17121855
[TBL] [Abstract][Full Text] [Related]
2. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
5. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25.
Kusakawa G; Saito T; Onuki R; Ishiguro K; Kishimoto T; Hisanaga S
J Biol Chem; 2000 Jun; 275(22):17166-72. PubMed ID: 10748088
[TBL] [Abstract][Full Text] [Related]
6. Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau.
Hashiguchi M; Saito T; Hisanaga S; Hashiguchi T
J Biol Chem; 2002 Nov; 277(46):44525-30. PubMed ID: 12226093
[TBL] [Abstract][Full Text] [Related]
7. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.
Saito T; Onuki R; Fujita Y; Kusakawa G; Ishiguro K; Bibb JA; Kishimoto T; Hisanaga S
J Neurosci; 2003 Feb; 23(4):1189-97. PubMed ID: 12598607
[TBL] [Abstract][Full Text] [Related]
8. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
9. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.
Patzke H; Tsai LH
J Biol Chem; 2002 Mar; 277(10):8054-60. PubMed ID: 11784720
[TBL] [Abstract][Full Text] [Related]
10. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
[TBL] [Abstract][Full Text] [Related]
11. The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.
He L; Zhang Z; Yu Y; Ahmed S; Cheung NS; Qi RZ
Cell Mol Life Sci; 2011 May; 68(9):1633-43. PubMed ID: 20976519
[TBL] [Abstract][Full Text] [Related]
12. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
[TBL] [Abstract][Full Text] [Related]
13. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
Smith PD; Mount MP; Shree R; Callaghan S; Slack RS; Anisman H; Vincent I; Wang X; Mao Z; Park DS
J Neurosci; 2006 Jan; 26(2):440-7. PubMed ID: 16407541
[TBL] [Abstract][Full Text] [Related]
14. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
[TBL] [Abstract][Full Text] [Related]
15. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
Zhang L; Liu W; Szumlinski KK; Lew J
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity induces cleavage of p35 to p25 by calpain.
Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
[TBL] [Abstract][Full Text] [Related]
17. p25/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons.
Saito T; Konno T; Hosokawa T; Asada A; Ishiguro K; Hisanaga S
J Neurochem; 2007 Jul; 102(1):133-40. PubMed ID: 17506859
[TBL] [Abstract][Full Text] [Related]
18. Involvement of calpain/p35-p25/Cdk5/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons.
Miao Y; Dong LD; Chen J; Hu XC; Yang XL; Wang Z
PLoS One; 2012; 7(8):e42318. PubMed ID: 22870316
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.
de Thonel A; Ferraris SE; Pallari HM; Imanishi SY; Kochin V; Hosokawa T; Hisanaga S; Sahlgren C; Eriksson JE
Mol Biol Cell; 2010 Apr; 21(8):1423-34. PubMed ID: 20200223
[TBL] [Abstract][Full Text] [Related]
20. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]